medmix publishes a midyear report as well as an annual report.
The global market of hot melt adhesives is projected to grow substantially through 2029*. One of the main drivers will be increased demand for advanced consumer electronic products. With the new MIXPAC 30 mL purHT 1K cartridge kit from medmix, end-users will be able to significantly boost their bonding performance and meet this trend.
In April 2023, a test program was performed to assess the compatibility of Nipro’s D2F™ pre-fillable syringes (“PFS”) with the PiccoJect 100 autoinjector from medmix. The test results confirm full compatibility of Nipro’s PFS with PiccoJect 100.
At today’s annual general meeting (AGM) of medmix Ltd, shareholders approved all proposals of the Board of Directors. Rob ten Hoedt was newly elected as Chairman. medmix will pay an ordinary dividend of CHF 0.50 per share to shareholders.
PiccoJect, the disposable, two-step autoinjector, designed for subcutaneous injection, has now been recognized for another prestigious design award, the Red Dot Award: Product Design 2023. The award will be presented to Haselmeier and DCA Design at the Red Dot Gala on June 19 in Essen, Germany.
medmix, a global leader in high-precision delivery devices, has won a landmark court ruling in Germany to help protect its customers from counterfeit products. Found to be in breach of Unfair Competition Law, a distributor of cattle care products in Baden-Württemberg agreed to a Judgement by Acknowledgement at Cologne District Court for selling imitations of the patented Quadro™ static mixing tips, owned by medmix, type MFQ (Court ref: 84 O 131/22).
medmix, global leader in high-precision delivery devices, is further strengthening its footprint in sustainable products and eco-design across all its segments, and delivers results. The company has committed to SBTi adopting the 1.5°C emission goal. It has successfully been assessed by CDP, and it has aligned with the UNGC principles. Separately, medmix has been awarded EcoVadis best-in-class ratings.
Ad hoc announcement pursuant to Art. 53 LR
FULL YEAR 2022 HIGHLIGHTS
Ad hoc announcement pursuant to Art. 53 LR
medmix announces negotiations for the sale of its Polish entity, following its decision to stop production in Wroclaw, Poland. The company revises its outlook for FY 2022, reflecting the impact of mitigating sanctions in Poland, ongoing inflationary pressures, and mix.
In line with its local for local growth strategy in China, medmix has signed an investment agreement to acquire a majority stake in Guangdong Qiaoyi Plastic Co. LTD, a beauty manufacturing business in Shantou.
medmix, global leader in high-precision delivery devices, won the prestigious Good Design™ Award 2022 in the Medical category for PiccoJect™, the autoinjector from medmix Drug Delivery (Haselmeier™). PiccoJect™ is a disposable two-step autoinjector designed for subcutaneous injection.
medmix works with a UK distributor to defend trademark rights and remove counterfeit products imitating its COXTM handheld sealant and adhesive dispensers from sale. Having successfully identified an illegal supply route, medmix now supports the distributor by providing an OEM supply of genuine, high-quality dispensers.
Ad hoc announcement pursuant to Art. 53 LR